Unum Therapeutics Announces 2019 Goals and Expected Milestones
– Multiple Data Readouts from ATTCK-20-03 and ATTCK-17-01 Expected in 2019 – – Initial Data on ATTCK-34-01, Unum’s First Program […]
Neon Therapeutics Provides Business Update and Outlook for 2019
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) — Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, […]
Axovant Announces Presentation at J.P. Morgan Healthcare Conference and Anticipated 2019 Clinical Development Milestones
Axovant’s CEO, Pavan Cheruvu, M.D., will be presenting at the J.P. Morgan Healthcare Conference at 8:00 a.m. PST on Thursday, […]
Amicus Therapeutics Announces Phase 1/2 Study of Gene Therapy for CLN3 Batten Disease
Second Gene Therapy to Enter Clinic at Nationwide Children’s Hospital for Neurologic Lysosomal Storage Disorders Initial Safety is Encouraging with […]
The Simply Good Foods Company Reports First Quarter 2019 Financial Results
DENVER, Jan. 03, 2019 (GLOBE NEWSWIRE) — The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods,” or the “Company”), […]
DSP Group Announces Appointment of IoT Expert Bill Scheffler as Vice President of Business Development
Company expands its U.S. presence to enhance adoption of IoT technologies SAN JOSE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) — […]
Plug Power to Host Business Update Conference Call on January 9, 2019 to Discuss Preliminary 2018 Results and 2019 Growth Plans
LATHAM, N.Y., Jan. 03, 2019 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of energy solutions that change […]
Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on […]
Helius Medical Technologies, Inc. Announces Third Collaboration to Implement Clinical Experience Programs with PoNS™ Treatment in the United States
NEWTOWN, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
Unum Therapeutics Announces Transition of Chief Financial Officer
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the […]
